Dietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese health study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 87, Issue 1, 2016, Pages 86-92

  Tan, Louis C ^a,b   Methawasin, Kulthida ^a   Tan, Eng King ^a,b   Tan, June H ^c   Au, Wing Lok ^a,b   Yuan, Jian Min ^d,e   Koh, Woon Puay ^b,f  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SATURATED FATTY ACID; CHOLESTEROL INTAKE; FAT INTAKE;

ADULT; AGED; ARTICLE; CHOLESTEROL DIET; CHOLESTEROL INTAKE; COHORT ANALYSIS; FAT INTAKE; FEMALE; HUMAN; LIPID DIET; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SINGAPORE; BLOOD; CHINA; DIET; DOSE RESPONSE; ETHNOLOGY; FOLLOW UP; HOSPITAL DISCHARGE; MEDICAL RECORD; MIDDLE AGED; QUESTIONNAIRE; RISK; STATISTICS AND NUMERICAL DATA;

AGED; CHINA; CHOLESTEROL, DIETARY; COHORT STUDIES; DIET; DIET RECORDS; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; PARKINSON DISEASE; PATIENT DISCHARGE; PROSPECTIVE STUDIES; RISK; SINGAPORE; SURVEYS AND QUESTIONNAIRES;

EID: 84956780477     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-310065     Document Type: Article

References (42)

1. Lim KL, Zhang CW. Molecular events underlying Parkinson's disease-an interwoven tapestry. Front Neurol 2013;4:33.
2. Colette C, Percheron C, Pares-Herbute N, et al. Exchanging carbohydrates for monounsaturated fats in energy-restricted diets: effects on metabolic profile and other cardiovascular risk factors. Int J Obes Relat Metab Disord 2003;27:648-56.
3. Moreno JJ, Mitjavila MT. The degree of unsaturation of dietary fatty acids and the development of atherosclerosis (review). J Nutr Biochem 2003;14:182-95.
4. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999;70:560S-9S.
5. Youdim KA, Martin A, Joseph JA. Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci 2000;18:383-99.
6. Vance JE. Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. Dis Model Mech 2012;5:746-55.
7. Liu JP, Tang Y, Zhou S, et al. Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol Cell Neurosci 2010;43:33-42.
8. Davies KN, King D, Davies H. A study of the nutritional status of elderly patients with Parkinson's disease. Age Ageing 1994;23:142-5.
9. Hellenbrand W, Boeing H, Robra BP, et al. Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology 1996;47:644-50.
10. Johnson CC, Gorell JM, Rybicki BA, et al. Adult nutrient intake as a risk factor for Parkinson's disease. Int J Epidemiol 1999;28:1102-9.
11. Logroscino G, Marder K, Cote L, et al. Dietary lipids and antioxidants in Parkinson's disease: A population-based, case-control study. Ann Neurol 1996;39:89-94.
12. Morens DM, Grandinetti A, Waslien CI, et al. Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake. Neurology 1996;46:1270-4.
13. Powers KM, Smith-Weller T, Franklin GM, et al. Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 2003;60:1761-6.
14. Abbott RD, Ross GW, White LR, et al. Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study. J Neurol 2003;250(Suppl 3):III30-III9.
15. Chen H, O'Reilly E, McCullough ML, et al. Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiol 2007;165:998-1006.
16. Chen H, Zhang SM, Hernan MA, et al. Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol 2003;157:1007-14.
17. de Lau LM, Bornebroek M, Witteman JC, et al. Dietary fatty acids and the risk of Parkinson disease: The Rotterdam study. Neurology 2005;64:2040-5.
18. Hankin JH, Stram DO, Arakawa K, et al. Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer 2001;39:187-95.
19. Lee EEF. Profile of the Singapore Chinese Dialect Groups. Statistics Singapore Newsletter [serial online]. http://www.howardscott.net/4/Swatow-A-Colonial.../Lee%20Eu%20Fah.pdf (accessed 5 Jan 2015).
20. Tan LC, Koh WP, Yuan JM, et al. Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. Am J Epidemiol 2008;167:553-60.
21. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-9.
22. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65:1220S-8S.
23. Miyake Y, Sasaki S, Tanaka K, et al. Dietary fat intake and risk of Parkinson's disease: A case-control study in Japan. J Neurol Sci 2010;288:117-22.
24. Powers KM, Smith-Weller T, Franklin GM, et al. Dietary fats, cholesterol and iron as risk factors for Parkinson's disease. Parkinsonism Relat Disord 2009;15:47-52.
25. Huang X, Chen H, Miller WC, et al. Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord 2007;22:377-81.
26. Miyake Y, Tanaka K, Fukushima W, et al. Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan. J Neurol Sci 2010;293:82-6.
27. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5:525-35.
28. Huang X, Abbott RD, Petrovitch H, et al. Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study. Mov Disord 2008;23:1013-18.
29. Simon KC, Chen H, Schwarzschild M, et al. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 2007;69:1688-95.
30. Huang X, Auinger P, Eberly S, et al. Serum cholesterol and the progression of Parkinson's disease: results from DATATOP. PLoS ONE 2011;6:e22854.
31. Du G, Lewis MM, Shaffer ML, et al. Serum cholesterol and nigrostriatal R2∗ values in Parkinson's disease. PLoS ONE 2012;7:e35397.
32. Lim L, Jackson-Lewis V, Wong LC, et al. Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease. Cell Death Differ 2012;19:416-27.
33. Musanti R, Parati E, Lamperti E, et al. Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease. Biochem Med Metab Biol 1993;49:133-42.
34. Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol 2001;12:105-12.
35. Pisani V, Stefani A, Pierantozzi M, et al. Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease. J Neuroinflammation 2012;9:188.
36. Alcalay RN, Gu Y, Mejia-Santana H, et al. The association between Mediterranean diet adherence and Parkinson's disease. Mov Disord 2012;27:771-4.
37. Bowen RA, Clandinin MT. Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium-potassium ATPase kinetics in developing rats. J Neurochem 2002;83:764-74.
38. Yaqoob P. Monounsaturated fatty acids and immune function. Eur J Clin Nutr 2002;56(Suppl 3):S9-S13.
39. Julien C, Berthiaume L, Hadj-Tahar A, et al. Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. Neurochem Int 2006;48:404-14.
40. Knopp RH, Paramsothy P, Retzlaff BM, et al. Sex differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease. Curr Cardiol Rep 2006;8:452-9.
41. Clifton PM, Nestel PJ. Influence of gender, body mass index, and age on response of plasma lipids to dietary fat plus cholesterol. Arterioscler Thromb 1992;12:955-62.
42. Kristal AR, Peters U, Potter JD. Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomarkers Prev 2005;14:2826-8.